摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-[(3-甲氧基苯基氨基)亚甲基]-2,2-二甲基-1,3-二噁烷-4,6-二酮 | 213699-52-6

中文名称
5-[(3-甲氧基苯基氨基)亚甲基]-2,2-二甲基-1,3-二噁烷-4,6-二酮
中文别名
2,2-二甲基-5-[(3-甲氧基苯基氨基)亚甲基]-1,3-二氧六环-4,6-二酮
英文名称
5-(((3-methoxyphenyl)amino)methylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione
英文别名
5-[[(3-methoxyphenyl)amino]methylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione;5-(((3-methoxyphenyl)amino)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione;5-((3-methoxyphenylamino)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione;5-[(3-Methoxy-phenylamino)-methylene]-2,2-dimethyl-[1,3]dioxan-4,6-dione;5-[(3-methoxyphenyl-amino)methylene]-2,2-dimethyl-[1,3]dioxane-4,6-dione;5-{[(3-methoxyphenyl)amino]methylene}-2,2-dimethyl-1,3-dioxane-4,6-dione;5-[(3-Methoxyphenylamino)methylene]-2,2-dimethyl-1,3-dioxane-4,6-dione;5-[(3-methoxyanilino)methylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione
5-[(3-甲氧基苯基氨基)亚甲基]-2,2-二甲基-1,3-二噁烷-4,6-二酮化学式
CAS
213699-52-6
化学式
C14H15NO5
mdl
MFCD02936591
分子量
277.277
InChiKey
VJUROJBWDHBLOX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    73.9
  • 氢给体数:
    1
  • 氢受体数:
    6

SDS

SDS:f59c169ce032398e7fc38de80b5a0bc6
查看

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Structure–activity relationships for ferriprotoporphyrin IX association and β-hematin inhibition by 4-aminoquinolines using experimental and ab initio methods
    摘要:
    In order to probe structure-activity relationships of association with ferriprotoporphyrin IX (logK) and inhibition of beta-hematin formation, a series of 4-aminoquinolines with varying substituents at the 7-position (X) have been synthesized. These have been further elaborated by introduction of two different R groups on the 4-amino nitrogen atom in the form of methyl (R = Me) and ethylamine (R = EtNH2) side chains. Data for a previously investigated series containing an N,N-diethyl-ethylamine side chain were also compared with the findings of this study. Experimentally, logK values for the simple 4-aminoquinoline series (R = H) were found to correlate with the hydrophobicity constant (pi) of the group X. The logK values for the series with R = Me and EtNH2 were found to correlate with those of the series with R = H. The log of the 50% beta-hematin inhibitory activity (log BHIA(50)) was found to correlate with logK and either meta (sigma(m)) or para (sigma(p)) Hammett constants for the series with R = Me and EtNH2, but not the simple series with R = H. To further improve predictability, correlations with ab initio electrostatic parameters, namely Mulliken and CHelpG charges were investigated. The best correlations were found with CHelpG charges which indicated that logK values can be predicted from the charges on atom H-8 and the group X in the quinolinium species computed in vacuum, while log BHIA50 values can be predicted from the CHelpG charges on C-7, C-8 and N-1 for the neutral species in vacuum. These correlations indicate that association and inhibition of beta-hematin formation are separately determined. They also suggest that electron withdrawing groups at the 7-position, but not necessarily hydrophobic groups are required for hemozoin inhibition. The upshot is that the correlations imply that considerably more hydrophilic hemozoin inhibitors are feasible. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2013.04.040
  • 作为产物:
    描述:
    5-(甲氧基甲烯基)-2,2-二甲基-1,3-二氧己环-4,6-二酮间氨基苯甲醚乙腈 为溶剂, 反应 0.25h, 以100%的产率得到5-[(3-甲氧基苯基氨基)亚甲基]-2,2-二甲基-1,3-二噁烷-4,6-二酮
    参考文献:
    名称:
    Regioselective Synthesis of Quinolin-4-ones by Pyrolysis of Anilinomethylene Derivatives of Meldrum’s Acid
    摘要:
    在闪速真空热解(FVP)条件下,梅氏酸的富电子和缺电子苯胺亚甲基衍生物通过亚胺酰基乙烯中间体环化成喹啉-4-酮的效率相同。
    DOI:
    10.1055/s-0029-1217383
点击查看最新优质反应信息

文献信息

  • [EN] HEPATITIS C VIRUS INHIBITORS<br/>[FR] INHIBITEURS DU VIRUS DE L'HEPATITE C
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2003099274A1
    公开(公告)日:2003-12-04
    Hepatitis C virus inhibitors are disclosed having the general formula:(I) wherein R1, R2, R3, R', B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds toinhibit HCV are also disclosed.
    丙型肝炎病毒抑制剂公开了具有以下通式:其中R1、R2、R3、R'、B、Y和X在描述中有所描述。还公开了包含该化合物的组合物以及使用该化合物抑制HCV的方法。
  • Gas-Phase Pyrolysis in Organic Synthesis: Rapid Green Synthesis of 4-Quinolinones
    作者:Nouria Al-Awadi、Ismail Abdelhamid、Ismail Abdelhamid、Alya Al-Etaibi、Mohamed Elngadi
    DOI:10.1055/s-2007-985573
    日期:——
    Gas-phase pyrolysis of aminomethylene Meldrum’s acid derivatives gave quinolinones and/or amines depending on the -nature of arylamino moiety. Effect of substituent on reaction rate and nature of pyrolysis products supports the suggested intramolecular nucleophilic substitution reaction via initially formed keteneamine intermediate.
    根据芳基氨基部分的性质,氨基亚甲基 Meldrum 的酸衍生物的气相热解得到喹啉酮和/或胺。取代基对反应速率和热解产物性质的影响支持通过最初形成的烯酮胺中间体进行的分子内亲核取代反应。
  • [EN] PROCESS FOR PREPARING SUBSTITUTED QUINOLIN-4-OL COMPOUNDS<br/>[FR] MÉTHODE DE PRÉPARATION DE COMPOSÉS DE QUINOLÉINE-4-OL SUBSTITUÉS
    申请人:CALITOR SCIENCES LLC
    公开号:WO2018026877A1
    公开(公告)日:2018-02-08
    The invention relates to a process for preparing substituted quinolin-4-ol compounds useful for preparing protein tyrosine kinase (PTK) inhibitors which are useful in treating cancer.
    本发明涉及一种制备取代喹啉-4-醇化合物的方法,该化合物用于制备蛋白酪氨酸激酶(PTK)抑制剂,该抑制剂可用于治疗癌症。
  • 取代的4-羟基喹啉类化合物的制备方法
    申请人:广东东阳光药业有限公司
    公开号:CN107641099A
    公开(公告)日:2018-01-30
    本发明涉及取代的4‑羟基喹啉类化合物的制备方法,该类化合物是用于制备治疗癌症的蛋白质酪氨酸激酶(PTK)抑制剂的中间体。
  • Hepatitis C virus inhibitors
    申请人:——
    公开号:US20040106559A1
    公开(公告)日:2004-06-03
    Hepatitis C virus inhibitors are disclosed having the general formula: 1 wherein R 1 , R 2 , R 3 , R′, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    本文披露了具有以下一般式的丙型肝炎病毒抑制剂:1,其中R1、R2、R3、R'、B、Y和X在说明书中有描述。还披露了包含这些化合物的组合物和使用这些化合物抑制HCV的方法。
查看更多